Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease (Q73487086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

J Krepinsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A J Ingram

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C M Clase

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

500-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

Prolonged hypoglycemia following acetohexamide administration. Report of two cases with impaired renal function

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Glibenclamide induced prolonged hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Comparative tolerability profiles of oral antidiabetic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Rates of hypoglycemia in users of sulfonylureas.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Severe Hypoglycaemia During Treatment with Glipizide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Hypoglycemia in hospitalized patients. Causes and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Effect of nutrition on morbidity and mortality in maintenance dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in β-cell-rich pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Behaviour of glibenclamide on repeated administration to diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Slow elimination of glyburide in NIDDM subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetics of glipizide in man: Influence of renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970204-6

7 January 2021

10.1016/S0272-6386(00)70204-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10692277%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference